Kainos Laboratories reports lower FY2026 parent net profit
Updated
Updated · MarketWatch · May 8
Kainos Laboratories reports lower FY2026 parent net profit
3 articles · Updated · MarketWatch · May 8
The Japanese company posted net profit of Y449 million for the year ended 31 March, versus Y641 million a year earlier, while revenue rose to Y5.48 billion from Y5.31 billion.
Operating profit fell to Y747 million from Y823 million and pretax profit slipped to Y788 million from Y828 million, with earnings per share declining to Y106.19 from Y152.06.
Kainos said annual dividends were Y0.00, compared with Y35.00 previously, and the results were prepared under Japanese accounting standards.
With profits plummeting despite rising sales, is Kainos a canary in the coal mine for Japan's entire pharmaceutical industry?
Denka acquired a struggling Kainos. What is its secret strategy to reverse the profit decline amid harsh government price cuts?